Skip to content

Non Invasive ventilation in Acute Asthma

Prospective,randomized,controlled trial of non-invasive ventilation in acute exacerbation of asthma in children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/02/007854
Enrollment
50
Registered
2017-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Suffering from acute severe asthma

Interventions

Intervention1: Non Invasive Ventilation: Children receiving NIV will be compared against the comparator group Control Intervention1: Standard Therapy of Acute Severe Bronchial Asthma: Children receivi

Sponsors

Chittaranjan Seva Sadan Kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children aged less than 15 year 2.Acute severe asthma [acute exacerbation of asthma not controlled with inhaled beta 2 agonists, moist oxygen inhalation and steroids with Becker score >7 3.Episode of acute onset wheeze in whom thorough elicitation of history from parents, clinical presentation and examination, make the diagnosis of bronchial asthma very likely according to the criteria laid down by British Thoracic Society

Exclusion criteria

Exclusion criteria: 1.Episode of acute onset wheeze in whom thorough elicitation of history from parents, clinical presentation and examination, make the diagnosis of bronchial asthma very unlikely according to the criteria laid down by British Thoracic Society 2.Children with modified GCS 7 or less and not able to maintain their airway protective reflexes 3.Those with having thick trachea-bronchial secretion 4.Intestinal obstruction 5.Any mid-face abnormality (i.e maxillary hypoplasia,small chin), facial burns 6.Severe vomiting 7.Fixed upper airway obstruction 8.Undrained pneumothorax 9.Vasoactive Inotrope score >10(i.e. inj. Dopamine >10 mcg/kg/minute) at the time of PICU admission.

Design outcomes

Primary

MeasureTime frame
i)To assess the effectiveness of non-invasive ventilation(NIV) as an adjunct therapy in acute exacerbation of bronchial asthma in children aged less than 15 years. ii)To compare duration of stay in intensive care unit amongst the control and NIV group.Timepoint: 1,2,4,12,24,48 hour

Secondary

MeasureTime frame
i) To see the rate of endotracheal intubation amongst the two study group: children receiving Standard therapy for bronchial asthma alone henceforth, classified as control group and children receiving Standard therapy for bronchial asthma plus NIV henceforth, classified as NIV groupTimepoint: 1, 2,4,12,24,28 hour

Countries

India

Contacts

Public ContactMd Rahiul Islam

Chittaranjan Seva Sadan, Kolkata

madhusmitasengupta@rediffmail.com9681055134

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026